Which has stronger earnings & valuation, CELUW or AIMDW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Celularity $26.55M N/A N/A N/A N/A Ainos $18.11K N/A N/A N/A N/A

Is CELUW or AIMDW more profitable?

Company Net Margins Return on Equity Return on Assets Celularity N/A N/A N/A Ainos N/A N/A N/A

Which has preferable valuation and earnings, ALVOW or CELUW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alvotech $559.42M N/A N/A N/A N/A Celularity $26.55M N/A N/A N/A N/A

Is ALVOW or CELUW more profitable?

Company Net Margins Return on Equity Return on Assets Alvotech N/A N/A N/A Celularity N/A N/A N/A

Does the media favor ALVOW or CELUW?

In the previous week, Alvotech and Alvotech both had 1 articles in the media. Alvotech's average media sentiment score of 0.67 beat Celularity's score of 0.00 indicating that Alvotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alvotech 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celularity 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, ARAV or CELUW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aravive N/A N/A N/A -$0.90 N/A Celularity $26.55M N/A N/A N/A N/A

Is ARAV or CELUW more profitable?

Company Net Margins Return on Equity Return on Assets Aravive N/A N/A N/A Celularity N/A N/A N/A

Which has better valuation & earnings, ACABW or CELUW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A Celularity $26.55M N/A N/A N/A N/A

Is ACABW or CELUW more profitable?

Company Net Margins Return on Equity Return on Assets Atlantic Coastal Acquisition Corp. II N/A N/A N/A Celularity N/A N/A N/A

Which has stronger earnings & valuation, BFRIW or CELUW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biofrontera $43.20M N/A N/A N/A N/A Celularity $26.55M N/A N/A N/A N/A

Is BFRIW or CELUW more profitable?

Company Net Margins Return on Equity Return on Assets Biofrontera N/A N/A N/A Celularity N/A N/A N/A

Does the media favor BFRIW or CELUW?

In the previous week, Biofrontera and Biofrontera both had 1 articles in the media. Biofrontera's average media sentiment score of 0.00 equaled Celularity'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biofrontera 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Celularity 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Celularity (CELUW) Competitors

$0.0019 0.00 (0.00%)

As of 07/23/2026

Compare

CELUW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Celularity stock or one of its competitors? MarketBeat compares Celularity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Celularity include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW).

How does Celularity compare to Ainos?

Celularity (NASDAQ:CELUW) and Ainos (NASDAQ:AIMDW) are related companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celularity	$26.55M	N/A	N/A	N/A	N/A
Ainos	$18.11K	N/A	N/A	N/A	N/A

In the previous week, Celularity had 1 more articles in the media than Ainos. MarketBeat recorded 1 mentions for Celularity and 0 mentions for Ainos. Celularity's average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company	Overall Sentiment
Celularity	Neutral
Ainos	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Celularity	N/A	N/A	N/A
Ainos	N/A	N/A	N/A

Summary

Celularity beats Ainos on 2 of the 2 factors compared between the two stocks.

How does Celularity compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Celularity (NASDAQ:CELUW) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, media sentiment, analyst recommendations and risk.

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
Celularity	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$559.42M	N/A	N/A	N/A	N/A
Celularity	$26.55M	N/A	N/A	N/A	N/A

In the previous week, Alvotech and Alvotech both had 1 articles in the media. Alvotech's average media sentiment score of 0.67 beat Celularity's score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alvotech	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Celularity	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Alvotech beats Celularity on 2 of the 2 factors compared between the two stocks.

How does Celularity compare to Aravive?

Aravive (NASDAQ:ARAV) and Celularity (NASDAQ:CELUW) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Company	Net Margins	Return on Equity	Return on Assets
Aravive	N/A	N/A	N/A
Celularity	N/A	N/A	N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aravive	N/A	N/A	N/A	-$0.90	N/A
Celularity	$26.55M	N/A	N/A	N/A	N/A

In the previous week, Celularity had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Celularity and 0 mentions for Aravive. Aravive's average media sentiment score of 0.00 equaled Celularity'saverage media sentiment score.

Company	Overall Sentiment
Aravive	Neutral
Celularity	Neutral

Summary

Aravive and Celularity tied by winning 2 of the 4 factors compared between the two stocks.

How does Celularity compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Celularity (NASDAQ:CELUW) are related companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A
Celularity	$26.55M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A
Celularity	N/A	N/A	N/A

In the previous week, Celularity had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Celularity and 0 mentions for Atlantic Coastal Acquisition Corp. II. Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Celularity'saverage media sentiment score.

Company	Overall Sentiment
Atlantic Coastal Acquisition Corp. II	Neutral
Celularity	Neutral

Summary

Celularity beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks.

How does Celularity compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Celularity (NASDAQ:CELUW) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends and analyst recommendations.

In the previous week, Biofrontera and Biofrontera both had 1 articles in the media. Biofrontera's average media sentiment score of 0.00 equaled Celularity'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biofrontera	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Celularity	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biofrontera	$43.20M	N/A	N/A	N/A	N/A
Celularity	$26.55M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Biofrontera	N/A	N/A	N/A
Celularity	N/A	N/A	N/A

Summary

Biofrontera beats Celularity on 1 of the 1 factors compared between the two stocks.

Get Celularity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CELUW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CELUW vs. The Competition

Export

Metric	Celularity	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$3.54B	$6.85B	$12.42B
Dividend Yield	N/A	3.78%	2.59%	10.03%
P/E Ratio	N/A	7.38	282.28	24.66
Price / Sales	N/A	1,199.83	563.21	75.35
Price / Cash	N/A	44.80	28.60	46.71
Price / Book	N/A	16.96	10.96	6.07
Net Income	N/A	-$12.56M	$3.49B	$347.99M
7 Day Performance	N/A	-1.80%	-0.63%	-0.44%
1 Month Performance	N/A	-8.44%	-5.23%	-4.81%
1 Year Performance	N/A	48.63%	62.07%	18.61%

Celularity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CELUW Celularity	N/A	$0.00 flat	N/A	N/A	$0.00	$26.55M	N/A	220
AIMDW Ainos	N/A	$0.08 -36.5%	N/A	N/A	$0.00	$18.11K	N/A	40	Gap Down High Trading Volume
ALVOW Alvotech	N/A	$0.15 flat	N/A	-90.6%	$0.00	$559.42M	N/A	4	Gap Up
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.00 flat	N/A	N/A	$0.00	N/A	N/A	15

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CELUW) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Celularity (CELUW) Competitors